Magennis D P
Department of Pathology, Glasgow Royal Infirmary, Scotland, UK.
Br J Biomed Sci. 1997 Jun;54(2):140-8.
In recent years molecular biology techniques have provided new insights into the nuclear mechanisms associated with carcinogenesis. These have led to renewed interest in the measurement of nuclear DNA for diagnosis, prediction of prognosis, and assessing tumour response to therapy. Cytogenetics has been used successfully for this purpose for several decades, but technical problems have largely restricted this to haematological malignancies. However, technological improvements in flow cytometry and image analysis, together with new molecular biology techniques for measuring nuclear DNA, are providing useful information on nuclear ploidy and proliferative activity in solid tumours. Although many problems remain in this field, these new and improved techniques for measuring nuclear DNA are beginning to find a role in diagnostic pathology.
近年来,分子生物学技术为与致癌作用相关的核机制提供了新的见解。这些见解引发了人们对测量核DNA用于诊断、预后预测以及评估肿瘤对治疗反应的新兴趣。几十年来,细胞遗传学已成功用于此目的,但技术问题在很大程度上限制了其仅用于血液系统恶性肿瘤。然而,流式细胞术和图像分析技术的改进,以及用于测量核DNA的新分子生物学技术,正在为实体瘤的核倍性和增殖活性提供有用信息。尽管该领域仍存在许多问题,但这些新的和改进的测量核DNA的技术已开始在诊断病理学中发挥作用。